MedPath

Effectiveness of mobile health (mHealth) intervention programme (mHealth-MS) on Metabolic Syndrome

Completed
Conditions
Healthy, prediabetics, Diabetics, Prehypertensive, Hypertensive, obase
Registration Number
CTRI/2017/09/009710
Lead Sponsor
Rajasthan University of Health Sciences
Brief Summary

Intensiveprograms like lifestyle modifications, drug adherence, exercise, etc. throughmobile phone messages to effect significantly reduce or delay the onset of MS. mHealthrefers to the utilization of mobile phones and other personal mobile devices asa platform for public health or medical interventions. The present study willbe undertaken with the objectives to study the prevalence of MS and to assessthe effect of mHealth-MS intervention programme on its selected components inrural population of Rajasthan. A community based intervention study including4000 subjects’ age 20 years & above will be selected using multi stagecluster sampling method & PRePArerisk assessment study’s questionnaire was used to study risk factors.Each cluster would be 100participants from each primary sampling unit (PSUs) and total no. of required clustersare 40. In this study comparing [1] standard of care (50%clusters)with standard of care plus a mobile phone based IVRS intervention [50% clusters]for 1 year among patients with MS. IVRS audio messages will be delivered health messagesand triggers to promote knowledge, healthy eating, exercise, self-efficacy, andmedication adherence for one year. After the development of tools and strategyand assessing the success of this intervention (midterm), research cum actionprojects will be developed for other regions of the Rajasthan.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
1000
Inclusion Criteria

1.all individual greater than or equal to twenty years of age 2.have metabolic syndrome 3.Has a text message–capable mobile phone 4.Know how to receive IVRS audio messages 5.Speak and read Hindi.

Exclusion Criteria

1.individual below 20 years of age 2.pregnant women 3.overt psychosis, 4.those participants who are not willing or in position to give consent due to any reason 5.Individuals with a previous physician diagnosis of hypertension or diabetes mellitus, who had not reported medication use.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Disease progression1 year
2. Knowledge about Diabetes, Hypertension, Obesity, Hypercholestromia1 year
Secondary Outcome Measures
NameTimeMethod
ï‚§Quality of Life (EQ-5D questionnaire)ï‚§ Cost effectiveness of IVRS interventions

Trial Locations

Locations (1)

RUHS College of Medical Sciences, Jaipur

🇮🇳

Jaipur, RAJASTHAN, India

RUHS College of Medical Sciences, Jaipur
🇮🇳Jaipur, RAJASTHAN, India
Dr Arvind Sharma
Principal investigator
8559814816
dranuaiims@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.